Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: May 1, 2025
SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2025.
Read more at globenewswire.com
